» Articles » PMID: 38188654

Multicenter Comparison of Analytical Interferences of 25-OH Vitamin D Immunoassay and Mass Spectrometry Methods by Endogenous Interferents and Cross-reactivity with 3-epi-25-OH-vitamin D

Overview
Journal Pract Lab Med
Specialty Biochemistry
Date 2024 Jan 8
PMID 38188654
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D (vit-D) deficiency is highly prevalent in the Korean population, highlighting the need for accurate measurements. In this study, the interferences by endogenous and cross-reactive substances were compared between routine vit-D immunoassays and mass spectrometry (MS) methods.

Methods: Two MS methods and 4 immunoassays from different manufacturers (Abbott, Beckman Coulter, Roche, Siemens) were compared. Residual samples that were icteric, lipemic, hemolyzed, high in rheumatoid factor, from myeloma patients, or patients undergoing hemodialysis were collected. Also, 4 levels of National Institute of Standards and Technology (NIST) Standard Reference Material 972a, and 12 samples serially spiked with 3-epi-25-OH-D were prepared.

Results: Significant interferences were observed in hemolytic (Roche), icteric (Beckman and Siemens) and lipemic samples (all 4 immunoassays). Level 4 NIST material and 3-epi-25-OH-D-spiked samples induced significant cross-reactivity, yielding higher total vit-D measurements in non-epimer-separating MS methods, and both the Beckman and Roche immunoassays.

Conclusion: Most observed interferences were consistent with manufacturers' claims, but overall improvement of immunoassay bias limits is required. Awareness of potential interference is important to increase the accuracy of vit-D measurements. Moreover, care is due when interpreting vit-D results of newborns, infants and less commonly, pregnant women, who are known to have physiologically high levels of the highly cross-reactive 3-epi-25-OH-D.

References
1.
Dimeski G . Interference testing. Clin Biochem Rev. 2008; 29 Suppl 1:S43-8. PMC: 2556582. View

2.
Carter G, Jones J, Shannon J, Williams E, Jones G, Kaufmann M . 25-Hydroxyvitamin D assays: Potential interference from other circulating vitamin D metabolites. J Steroid Biochem Mol Biol. 2016; 164:134-138. DOI: 10.1016/j.jsbmb.2015.12.018. View

3.
Bailey D, Veljkovic K, Yazdanpanah M, Adeli K . Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem. 2012; 46(3):190-6. DOI: 10.1016/j.clinbiochem.2012.10.037. View

4.
Mineva E, Schleicher R, Chaudhary-Webb M, Maw K, Botelho J, Vesper H . A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D₃ and 25-hydroxyvitamin D₂ using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2015; 407(19):5615-24. PMC: 4823009. DOI: 10.1007/s00216-015-8733-z. View

5.
Stepman H, Vanderroost A, Van Uytfanghe K, Thienpont L . Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011; 57(3):441-8. DOI: 10.1373/clinchem.2010.152553. View